Medtronic plc

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:30:02 15/06/2024 am IST			5-day change	1st Jan Change
81.04 ^USD	-0.76%		-3.60%	-1.63%

12/06	Medtronic Insider Sold Shares Worth $1,601,001, According to a Recent SEC Filing	MT
11/06	Transcript : Medtronic plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM

Medtronic plc Reports Earnings Results for the Full Year Ended April 26, 2024

May 23, 2024 at 04:15 pm IST

Medtronic plc reported earnings results for the full year ended April 26, 2024. For the full year, the company reported sales was USD 32,364 million compared to USD 31,227 million a year ago. Net income was USD 3,676 million compared to USD 3,758 million a year ago.

Basic earnings per share from continuing operations was USD 2.77 compared to USD 2.83 a year ago. Diluted earnings per share from continuing operations was USD 2.76 compared to USD 2.82 a year ago.

Latest news about Medtronic plc

Medtronic Insider Sold Shares Worth $1,601,001, According to a Recent SEC Filing	12/06	MT
Transcript : Medtronic plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM	11/06
Medtronic plc Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024	05/06	CI
Medtronic Closes Offering of 3 Billion Euros of Notes	03/06	MT
Daiwa Securities Adjusts Price Target on Medtronic to $92 From $100	30/05	MT
Medtronic Prices 3 Billion Euros Senior Notes Offering	30/05	MT
Medtronic is hiding behind its status as dividend aristocrat	27/05
UBS Adjusts Medtronic Price Target to $76 From $75, Maintains Sell Rating	24/05	MT
Bernstein Adjusts Price Target on Medtronic to $96 From $97	24/05	MT
Truist Securities Adjusts Price Target on Medtronic to $88 From $90, Keeps Hold Rating	24/05	MT
Wolfe Research Adjusts Price Target on Medtronic to $82 From $80	24/05	MT
Baird Adjusts Price Target on Medtronic to $87 From $88	24/05	MT
Wells Fargo Adjusts Price Target on Medtronic to $105 From $102	24/05	MT
Sector Update: Health Care Stocks Retreat Late Afternoon	24/05	MT
Health Care Limits Losses Amid Defensive Bias - Health Care Roundup	24/05	DJ
Sector Update: Health Care Stocks Lower Thursday Afternoon	24/05	MT
Sector Update: Health Care	24/05	MT
Piper Sandler Adjusts Medtronic's Price Target to $85 From $87, Keeps Neutral Rating	24/05	MT
Some of the biggest splits in Corporate America	23/05	RE
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday	23/05	MT
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	23/05
Medtronic Guides for Annual Growth in Fiscal 2025 as Fourth-Quarter Results Top Views	23/05	MT
Medtronic's Fiscal Q4 Non-GAAP Earnings Fall, Net Sales Rise; Fiscal 2025 Guidance Issued; Quarterly Dividend Lifted	23/05	MT
Stock Futures Climb Pre-Bell Boosted by Nvidia's Financial Results; Asia Falls, Europe Strong	23/05	MT
Earnings Flash (MDT) MEDTRONIC Posts Q4 Revenue $8.59B, vs. Street Est of $8.44B	23/05	MT

Chart Medtronic plc

Duration

Period

More charts

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

28/06/2024 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Medtronic is hiding behind its status as dividend aristocrat

May 27, 2024 at 02:56 pm IST

More Strategies

Ratings for Medtronic plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

81.04 USD

Average target price

94.07 USD

Spread / Average Target

+16.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MEDTRONIC PLC	-1.63%	106B
ABBOTT LABORATORIES	-5.81%	180B
BECTON, DICKINSON AND COMPANY	-4.14%	67.55B
DEXCOM, INC.	-6.56%	46.11B
CENCORA, INC.	+13.22%	45.79B
HOYA CORPORATION	+6.13%	41.61B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.93%	31.07B
TERUMO CORPORATION	+13.61%	24.77B
WEST PHARMACEUTICAL SERVICES, INC.	-5.36%	24.27B
ZIMMER BIOMET HOLDINGS, INC.	-11.92%	22.05B

Other Medical Equipment, Supplies & Distribution